Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study
We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds rat...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2022
|
| _version_ | 1797108143862317056 |
|---|---|
| author | Ayoubkhani, D Bosworth, ML King, S Pouwels, KB Glickman, M Nafilyan, V Zaccardi, F Khunti, K Alwan, NA Walker, AS |
| author_facet | Ayoubkhani, D Bosworth, ML King, S Pouwels, KB Glickman, M Nafilyan, V Zaccardi, F Khunti, K Alwan, NA Walker, AS |
| author_sort | Ayoubkhani, D |
| collection | OXFORD |
| description | We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds ratio, 0.59 [95% confidence interval, .50–.69]), emphasizing the need for public health initiatives to increase population-level vaccine uptake. |
| first_indexed | 2024-03-07T07:25:16Z |
| format | Journal article |
| id | oxford-uuid:0df596b0-38a1-44b6-8c55-7be2df824eff |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:25:16Z |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | dspace |
| spelling | oxford-uuid:0df596b0-38a1-44b6-8c55-7be2df824eff2022-11-18T06:58:32ZRisk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0df596b0-38a1-44b6-8c55-7be2df824effEnglishSymplectic ElementsOxford University Press2022Ayoubkhani, DBosworth, MLKing, SPouwels, KBGlickman, MNafilyan, VZaccardi, FKhunti, KAlwan, NAWalker, ASWe investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds ratio, 0.59 [95% confidence interval, .50–.69]), emphasizing the need for public health initiatives to increase population-level vaccine uptake. |
| spellingShingle | Ayoubkhani, D Bosworth, ML King, S Pouwels, KB Glickman, M Nafilyan, V Zaccardi, F Khunti, K Alwan, NA Walker, AS Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study |
| title | Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study |
| title_full | Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study |
| title_fullStr | Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study |
| title_full_unstemmed | Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study |
| title_short | Risk of long COVID in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine: community-based, matched cohort study |
| title_sort | risk of long covid in people infected with severe acute respiratory syndrome coronavirus 2 after 2 doses of a coronavirus disease 2019 vaccine community based matched cohort study |
| work_keys_str_mv | AT ayoubkhanid riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT bosworthml riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT kings riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT pouwelskb riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT glickmanm riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT nafilyanv riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT zaccardif riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT khuntik riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT alwanna riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy AT walkeras riskoflongcovidinpeopleinfectedwithsevereacuterespiratorysyndromecoronavirus2after2dosesofacoronavirusdisease2019vaccinecommunitybasedmatchedcohortstudy |